KI researchers led by hematologist/oncologist and Charles W. (1955) and Jennifer C. Johnson Clinical Investigator Hojun Li have patented a blood-based lateral flow test to measure the level of Sars-CoV-2 neutralizing antibodies. The technology, for which the team is currently seeking manufacturing partners, provides valuable insight to inform decision-making around Covid-19 precautions—particularly for vulnerable patient populations—and can be customized to detect immunity against existing and future variants. The work, which was funded in part by the Holloway Foundation, was published in Cell Reports Methods. Read more at STAT News or USA Today or watch Li’s interview on CBS Boston.